Effect of Combined Red and Near Infrared Light-emitting Diode (LED) Therapy on Tissue Regeneration Post Laser Treatment

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-01

Study Completion Date

2024-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effect of light therapy on wound healing after laser treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Laser Treatment in Early Wound Healing to Promote Physiological Skin Remodeling

NCT03253484

Scar Improvement by Laser

UNKNOWN NA

Study of the Effects of the Pulsed-dye Laser at 585nm and 595nm to Treat Post-operative Scars on Suture-removal Day

NCT00482144

Cicatrix Scars

COMPLETED NA

HeaLED: Pilot Study of Skin Healing Under LED Exposure

NCT02677194

Healthy

COMPLETED NA

Impact of Preoperative Local Water-Filtered Infrared-A (wIRA) Irradiation on Postoperative Wound Healing

NCT01654679

Wound Infection Rate After Surgery Impact of Wound Infection on Pain and Wound Healing

COMPLETED NA

Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts

NCT04483934

Trophic Ulcer Non-healing Wound Non-Healing Ulcer of Skin

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study sets out to evaluate the effect of a combination of near infrared (830 nm) red (633 nm) and blue (465nm) light-emitting diode (LED) therapy on wound healing after laser application.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound Heal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a split-person study design where each participant has one arm with the intervention and the other arm that is control.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LED treatment

LED treatment with Celluma POD device after laser test area

Group Type EXPERIMENTAL

Celluma POD

Intervention Type DEVICE

A blue and near infrared handheld LED device

Control

No treatment after laser test area

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Celluma POD

A blue and near infrared handheld LED device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adults aged 18 years or older with no active cutaneous disease on bilateral ventral biceps, close to the axilla.

Subjects shall have given written informed consent for both the LED therapy and for clinical photography.

Exclusion Criteria

* Subjects refuse to give informed consent for either the phototherapy or the clinical photography.
* Subjects have previous photosensitivity problems (solar urticaria, etc.).
* Subjects are taking any systemic drug or applying any topical drug with known photosensitizing properties.
* Subjects taking any systemic drug with known immunosuppressant properties.
* Subjects applying any medications to the research site (inner biceps, close to the axilla).
* Subjects have medical or psychosocial conditions associated with a risk of poor protocol compliance.
* Subjects are smokers or have smoked within the last 30 days prior to the trial.
* Subjects have epilepsy or a history of seizures
* Subjects currently taking cortisone injections or any other kind of steroid injections(s)
* Subjects with known cancer tumor in the treatment area or metastasis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes